Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.

4 Ottawa 0101 only delivered PORT and found a numerically higher 10-year biochemical relapse-free survival rate (87.4% v 80.5%) with concurrent/adjuvant ADT, although it did not reach statistical significance ( P = .1), likely secondary to a lack of statistical power, given the lower-than-expected event rate. 6 An IPD meta-analysis of patients receiving PORT on both of these trials showed significantly improved long-term PFS and MFS with an adjuvant ADT approach. 7 The current pooled analysis with a muc

also in 111,027 other papers